40425_2019_705_MOESM1_ESM.png (20.32 kB)
Additional file 1: of Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy
figure
posted on 2019-10-23, 08:26 authored by Hao Liu, Zhen Zhao, Li Zhang, Yuanke Li, Akshay Jain, Ashutosh Barve, Wei Jin, Yanli Liu, John Fetse, Kun ChengFigure S1. Blockade of the PD-L1/CD80 interaction by anti-PD-L1 peptides and antibody. (a) Blocking efficiency of the anti-PD-L1 peptides and anti-human PD-L1 antibody at 10 μM against the human PD-L1/CD80 interaction. IC50 and blocking efficiency of CLP002 (b) and CLP003 (c) against the human PD-L1/CD80 interaction. Results are represented as the mean ± SD (n = 3).
